SANUWAVE Health Inc (QB) (SNWV) Actualités

SANUWAVE Announces Record Quarterly Revenues:  Q3 FY2024 Financial Results

Q3 2024 revenues were $9.4 million, up 89% from Q3 2023.  This was an all-time quarterly record for the Company.  Q3 2024 gross...

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 - Securities to be offered to employees in employee benefit plans

SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering

1-for-375 reverse stock split effective at market open today Exchanged $43.2 million in principal amount of convertible notes and warrants...

Form 8-K - Current report

Form 3 - Initial statement of beneficial ownership of securities

SANUWAVE Health Announces 1-For-375 Reverse Stock Split

Common Stock Will Begin Trading on a Split-adjusted Basis on October 18, 2024EDEN PRAIRIE, MN -- October 16, 2024 -- InvestorsHub NewsWire...

SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results

Q2 2024 revenues were $7.2 million, up 53% from Q2 2023. This was an all-time quarterly record for the Company. Q2 2024 Gross Margin was 73...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results

SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results EDEN PRAIRIE, MN -- August 8, 2024...

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Form 8-K - Current report